X-Therma Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 30

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $500K

  • Investors
  • 17

X-Therma General Information

Description

Provider of biopreservation technology intended for long-term storage of biological materials. The company leverages proprietary peptoid technology to inhibit ice crystal formation, allowing sub-zero storage of cells, tissues, and organs while maintaining their functionality and viability, enabling healthcare and research institutions to preserve samples effectively, supporting advancements in regenerative medicine and transplantation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 625 Alfred Nobel Drive
  • Suite B
  • Hercules, CA 94547
  • United States
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Corporate Office
  • 625 Alfred Nobel Drive
  • Suite B
  • Hercules, CA 94547
  • United States

X-Therma Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

X-Therma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 22-Apr-2026 $500K Completed Generating Revenue
7. Secondary Transaction - Private 11-Aug-2024 Completed Generating Revenue
6. Later Stage VC (Series B) 08-Mar-2024 Completed Generating Revenue
5. Grant 31-Dec-2021 Completed Product Development
4. Later Stage VC (Series A) 12-Nov-2021 Completed Product Development
3. Seed Round 02-Jan-2019 Completed Startup
2. Accelerator/Incubator Completed Startup
1. Grant $9.2M Completed Startup
To view X-Therma’s complete valuation and funding history, request access »

X-Therma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-3
Series A-2
Series A-1
Series A
Seed-2
Seed-1 277,776 $0.000001 8% $2.07 $2.07 1x $2.07 2.24%
Seed 38,610 $0.000001 8% $2.59 $2.59 1x $2.59 0.31%
To view X-Therma’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

X-Therma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of biopreservation technology intended for long-term storage of biological materials. The company leverages pro
Biotechnology
Hercules, CA
30 As of 2026

Duluth, GA
 

Itasca, IL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

X-Therma Competitors (2)

One of X-Therma’s 2 competitors is Bridge to Life, a Venture Capital-Backed company based in Duluth, GA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bridge to Life Venture Capital-Backed Duluth, GA
Lifeline Scientific Formerly VC-backed Itasca, IL
You’re viewing 2 of 2 competitors. Get the full list »

X-Therma Patents

X-Therma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-D1126420-S1 Organ and tissue transport device Active 17-Sep-2025
US-D1157109-S1 Organ and tissue container Active 30-May-2025
US-D1157110-S1 Organ and tissue transport device Active 30-May-2025
EP-4711993-A1 Method for planned control of the operation of a heat and/or cold generator Pending 17-Sep-2024
CA-226150-S Organ and tissue transport device Active 31-May-2023
To view X-Therma’s complete patent history, request access »

X-Therma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

X-Therma Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
DecentraNet Venture Capital Minority
LIFTT Venture Capital Minority
Starling Locke Capital Venture Capital Minority
United States Department of War Government
2b AHEAD Ventures Venture Capital Minority
You’re viewing 5 of 17 investors. Get the full list »

X-Therma FAQs

  • When was X-Therma founded?

    X-Therma was founded in 2014.

  • Where is X-Therma headquartered?

    X-Therma is headquartered in Hercules, CA.

  • What is the size of X-Therma?

    X-Therma has 30 total employees.

  • What industry is X-Therma in?

    X-Therma’s primary industry is Biotechnology.

  • Is X-Therma a private or public company?

    X-Therma is a Private company.

  • What is X-Therma’s current revenue?

    The current revenue for X-Therma is .

  • How much funding has X-Therma raised over time?

    X-Therma has raised $37.2M.

  • Who are X-Therma’s investors?

    DecentraNet, LIFTT, Starling Locke Capital, United States Department of War, and 2b AHEAD Ventures are 5 of 17 investors who have invested in X-Therma.

  • Who are X-Therma’s competitors?

    Bridge to Life and Lifeline Scientific are competitors of X-Therma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process